User menu

Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial

Bibliographic reference Kay, J. ; Durez, Patrick ; Matteson, E. L. ; Dasgupta, B. ; Nash, P. ; et. al. Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial.Annual European Congress of Rheumatology (EULAR 2007) (Barcelona (Spain), Jun 13-16, 2007). In: Annals of the Rheumatic Diseases, Vol. 66, p. 175-176 (2007)
Permanent URL http://hdl.handle.net/2078.1/59327